+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin



Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin



Current Opinion in Immunology 5(1): 103-107



The bactericidal/permeability increasing protein is a major element in the host defense against Gram-negative bacteria and endotoxin, acting intracellularly in the polymorphonuclear leukocyte. As an isolated protein, bactericidal/permeability increasing protein also acts as an extracellular bactericidal and endotoxin-neutralizing agent and, when injected, protects animals against lethal effects of Gram-negative bacteria and endotoxin.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 030251586

Download citation: RISBibTeXText

PMID: 8452666

DOI: 10.1016/0952-7915(93)90088-a


Related references

Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin. Ciba Foundation Symposium 186: 176-87; Discussion 187-9, 1994

Host protection against gram negative bacteria and endotoxin by the bactericidal permeability increasing protein bpi of neutrophils. Journal of Cellular Biochemistry Suppl. (16 Part C): 150, 1992

The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 187(3-5): 417-429, 1993

Bactericidal/permeability-increasing protein (Bpi) and lipopolysaccharide-binding protein (Lbp): structure, function and regulation in host defence against Gram-negative bacteria. Biochemical Society Transactions 31(4): 785-790, 2003

Bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein Structure, function and regulation in host defence against Gram-negative bacteria. Biochemical Society Transactions 31(4): 785-790, 2003

Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria. Biochemical Society Transactions 31(Pt 4): 785-790, 2003

Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein. Infection and Immunity 63(1): 333-339, 1995

Enhancement of neonatal innate defense Effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and TNF-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Pediatric Research 47(4 Part 2): 268A, 2000

Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria. Journal of Immunology 180(11): 7546-7552, 2008

Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry 36(33): 10311-9, 1997

Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo. Infection and Immunity 68(9): 5120-5125, 2000

Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. Journal of Clinical Investigation 71(3): 540-549, 1983

Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein. International Journal of Antimicrobial Agents 42(6): 571-574, 2013

In whole blood ex vivo the human bactericidal permeability increasing protein and a recombinant amino terminal fragment cause killing of surviving gram negative bacteria and inhibit tnf release induced by the bacteria. Clinical Research 40(2): 213A, 1992

Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. Journal of Clinical Investigation 90(3): 1122-1130, 1992